Re: Sad news about Dr. Ludden
It is sad to learn about Dr Tom Ludden’s demise. I would like to share my
INTERACTION with him.
$THETA Our initial meeting happened when I was at Georgetown University,
Washington DC and he was with ICON (or its precursor). If I remember correctly,
Dr Carl Peck encouraged Dr Ludden to join the FDA. The first estimate of his
impact was realized when I joined FDA, by which time he already left FDA. Dr
Ludden was able to attract some of the top scientists to join FDA, which was a
challenge in those days. He continued his professorial spirit by teaching
pharmacometrics to aspiring clinical pharmacologists. Gradually, our meetings
converged on topics related to strategic direction of the field. He was kind
enough to meet with me to inspire me and offer sound advice. He was always at
the global minimum, was a true ‘gentleman’ through our iterations. Dr Ludden
laid one of the initial foundations of Pharmacometrics at FDA. His
contributions to the NONMEM community are well known. I cannot $ESTIMATE his
impact on our field both through transforming FDA reviews and making NONMEM
more useful for scientists. There is no uncertainty that the shoes he walked in
cannot be filled by anybody (;$COVARIANCE).
In conclusion, he left a strong $PRIOR; and $SIMULATION predicts that his
impact will continue to last forever! I will always remember him.
Joga
Quoted reply history
From: [email protected] <[email protected]> on behalf of
Riley, Steve <[email protected]>
Date: Friday, August 2, 2024 at 2:53 PM
To: [email protected] <[email protected]>
Subject: [NMusers] Sad news about Dr. Ludden
You don't often get email from [email protected]. Learn why this is
https://aka.ms/LearnAboutSenderIdentification
CAUTION: This message originated from a non-UMB email system. Hover over any
links before clicking and use caution opening attachments.
Dear NM-Users,
Regrettably, I am writing to let you know that Dr. Ludden passed away Tuesday
evening, 30JUL2024.
I was able to get there over the weekend prior to visit him and his family.
During his wakeful moments we had some good scientific discussions.
We talked a lot about NONMEM and how its functionality and utility has expanded
since he retired. He was pleased to hear about the changes.
He was surrounded by family for the days leading up to the end. They were all
appreciative that I was able to get there and tell him (and them) how much he
meant to all of us and the impact he had on our careers.
I think memories of Dr. Ludden were characterized perfectly by Marc Gastonguay,
“I am forever grateful for the positive impact that Tom had on my life and
career, not to mention the tremendous, although often underappreciated,
contributions he made to the disciplines of clinical pharmacology and
pharmacometrics. His humble brilliance will be missed and fondly remembered.”
Steve Riley